---
title: "Perrigo Company plc (PRGO.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/PRGO.US.md"
symbol: "PRGO.US"
name: "Perrigo Company plc"
industry: "Pharmaceuticals"
datetime: "2026-05-21T05:19:49.033Z"
locales:
  - [en](https://longbridge.com/en/quote/PRGO.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/PRGO.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/PRGO.US.md)
---

# Perrigo Company plc (PRGO.US)

## Company Overview

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women’s health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.perrigo.com](https://www.perrigo.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: D
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:16.000Z

**Overall: D (0.71)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 130 / 189 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: D

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -3.62% |  |
| Net Profit YoY | -908.66% |  |
| P/B Ratio | 0.62 |  |
| Dividend Ratio | 10.39% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1544184313.20 |  |
| Revenue | 4178400000.00 |  |

#### Multi Score Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -52.23% | E |
| Profit Margin | -43.50% | E |
| Gross Margin | 33.58% | C |
| Revenue YoY | -3.62% | D |
| Net Profit YoY | -908.66% | E |
| Total Assets YoY | -18.20% | E |
| Net Assets YoY | -42.74% | E |
| Cash Flow Margin | -10.42% | D |
| OCF YoY | -3.62% | D |
| Turnover | 0.47 | C |
| Gearing Ratio | 68.70% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Perrigo Company plc",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-3.62%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-908.66%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.62",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "10.39%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1544184313.20",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "4178400000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "-52.23%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-43.50%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "33.58%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "-3.62%",
          "rating": "D"
        },
        {
          "name": "Net Profit YoY",
          "value": "-908.66%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-18.20%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-42.74%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-10.42%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "-3.62%",
          "rating": "D"
        },
        {
          "name": "Turnover",
          "value": "0.47",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "68.70%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.85 | 98/189 | - | - | - |
| PB | 0.62 | 25/189 | 0.82 | 0.59 | 0.44 |
| PS (TTM) | 0.37 | 12/189 | 0.83 | 0.48 | 0.39 |
| Dividend Yield | 10.39% | 2/189 | 9.81% | 7.76% | 4.33% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-07T04:00:00.000Z

Total Analysts: **5**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 20% |
| Overweight | 1 | 20% |
| Hold | 3 | 60% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 11.16 |
| Highest Target | 20.00 |
| Lowest Target | 15.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/PRGO.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/PRGO.US/norm.md)
- [Related News](https://longbridge.com/en/quote/PRGO.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/PRGO.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**